Bologna, Italy

Davide Gibellini


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Davide Gibellini: Innovator in Antipathogenic Peptides

Introduction

Davide Gibellini is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of peptides with antipathogenic properties. His work focuses on creating solutions for medical applications, especially in combating viral and bacterial infections.

Latest Patents

Gibellini holds a patent for "Antipathogenic peptides." This invention relates to monomeric and multimeric peptidic compounds that exhibit antipathogenic activity, specifically targeting both antiviral and antibacterial effects. The peptide compounds developed by Gibellini are effective against a broad spectrum of viruses, including both DNA and RNA viruses, regardless of whether they possess a viral envelope. Additionally, the invention encompasses compositions that include these peptidic compounds for medical use, aimed at the treatment or prevention of pathogenic infections.

Career Highlights

Davide Gibellini is associated with Spiderbiotech S.r.l., where he continues to advance his research and development efforts. His work at this company emphasizes the importance of innovative solutions in the healthcare sector, particularly in the fight against infectious diseases.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Davide Gibellini's contributions to the field of biotechnology through his innovative work on antipathogenic peptides highlight the potential for new medical treatments. His patent reflects a significant step forward in addressing viral and bacterial infections, showcasing the importance of ongoing research in this vital area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…